Xanthomicrol Exerts Antiangiogenic and Antitumor Effects in a Mouse Melanoma (B16F10) Allograft Model.


Journal

Evidence-based complementary and alternative medicine : eCAM
ISSN: 1741-427X
Titre abrégé: Evid Based Complement Alternat Med
Pays: United States
ID NLM: 101215021

Informations de publication

Date de publication:
2020
Historique:
received: 18 07 2020
revised: 01 12 2020
accepted: 13 12 2020
entrez: 11 1 2021
pubmed: 12 1 2021
medline: 12 1 2021
Statut: epublish

Résumé

Xanthomicrol, a trimethoxylated hydroxyflavone, is the main active component of

Identifiants

pubmed: 33424993
doi: 10.1155/2020/8543872
pmc: PMC7772032
doi:

Types de publication

Journal Article

Langues

eng

Pagination

8543872

Informations de copyright

Copyright © 2020 Foad Ghazizadeh et al.

Déclaration de conflit d'intérêts

The authors declare that there are no conflicts of interest.

Références

Phytother Res. 2012 Jul;26(7):1023-8
pubmed: 22184071
J Invest Dermatol. 2004 Feb;122(2):337-41
pubmed: 15009714
J Exp Clin Cancer Res. 2008 Nov 04;27:60
pubmed: 18983651
Br J Cancer. 2015 Jan 20;112(2):217-26
pubmed: 25180764
Leukemia. 1999 Mar;13(3):469-72
pubmed: 10086738
Br J Cancer. 1998 Mar;77(6):897-902
pubmed: 9528831
J Clin Invest. 2015 Sep;125(9):3338-46
pubmed: 26241053
Leukemia. 2004 Mar;18(3):624-7
pubmed: 14749707
Cancer. 1976 Jul;38(1):187-92
pubmed: 947514
N Engl J Med. 2011 Jun 30;364(26):2507-16
pubmed: 21639808
Lab Invest. 1966 Feb;15(2):464-78
pubmed: 5932611
Methods Mol Biol. 2016;1430:3-33
pubmed: 27172943
Phytother Res. 2014 Nov;28(11):1661-70
pubmed: 24895220
J Invest Dermatol. 2004 Dec;123(6):1151-61
pubmed: 15610528
Cancer Cell. 2005 Dec;8(6):443-54
pubmed: 16338658
J Pharmacopuncture. 2018 Mar;21(1):26-34
pubmed: 30151302
Exp Mol Med. 2008 Oct 31;40(5):486-94
pubmed: 18985006
Nat Genet. 2009 May;41(5):544-52
pubmed: 19282848
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4082-5
pubmed: 7513432
Pharmacol Res. 2017 May;119:327-346
pubmed: 28242334
J Clin Oncol. 2001 Jan 15;19(2):577-83
pubmed: 11208853
Cancer Res. 2007 Apr 1;67(7):3177-84
pubmed: 17409425
J Clin Oncol. 2001 Feb 15;19(4):1207-25
pubmed: 11181687
Ann Oncol. 2004 Aug;15(8):1151-60
pubmed: 15277253
Semin Oncol Nurs. 2013 Aug;29(3):160-9
pubmed: 23958214
Mediators Inflamm. 2017;2017:3264217
pubmed: 28848246
N Engl J Med. 1971 Nov 18;285(21):1182-6
pubmed: 4938153
Ther Adv Med Oncol. 2010 Nov;2(6):367-80
pubmed: 21789148
Nat Med. 2003 Jun;9(6):669-76
pubmed: 12778165
Curr Protoc Immunol. 2001 May;Chapter 20:Unit 20.1
pubmed: 18432774
Phytochemistry. 2005 Jul;66(13):1581-92
pubmed: 15949825
Daru. 2016 Oct 4;24(1):22
pubmed: 27716340
Br J Haematol. 2002 Dec;119(3):665-71
pubmed: 12437642
Semin Cancer Biol. 2015 Dec;35 Suppl:S224-S243
pubmed: 25600295
Adv Cancer Res. 2009;102:19-65
pubmed: 19595306
Lancet. 2012 Jul 28;380(9839):358-65
pubmed: 22735384
Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5962-7
pubmed: 14676121

Auteurs

Foad Ghazizadeh (F)

Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Hemmat Highway, Tehran 14496, Iran.

Massoumeh Shafiei (M)

Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Hemmat Highway, Tehran 14496, Iran.

Reza Falak (R)

Department of Immunology, School of Medicine, Iran University of Medical Sciences, Hemmat Highway, Tehran 14496, Iran.

Mahshid Panahi (M)

Department of Pathology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran 15937, Iran.

Naser Rakhshani (N)

Department of Pathology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran 15937, Iran.

Soltan Ahmed Ebrahimi (SA)

Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Hemmat Highway, Tehran 14496, Iran.

Parvaneh Rahimi-Moghaddam (P)

Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Hemmat Highway, Tehran 14496, Iran.

Classifications MeSH